Safety, tolerability and pharmacokinetics of escalating doses of NXY-059 in healthy young and elderly subjects

By Wemer Johan   Cheng Yi-Fang   Nilsson Dag   Reinholdsson Ingalill   Fransson Bo   Lanbeck Vallén Kerstin   Nyman Lars   Eriksson Catarina   Björck Staffan   Schulman Sam  

Current Medical Research and Opinion, Vol. 22, Iss. 9, 2006-09 ,pp. : 1813-1823

Informa Healthcare

Access to resources Recommend Favorite

Dose-escalation study of the pharmacokinetics and pharmacodynamics of rivaroxaban in healthy elderly subjects

By Kubitza Dagmar   Becka Michael   Roth Angelika   Mueck Wolfgang  

Current Medical Research and Opinion, Vol. 24, Iss. 10, 2008-10 ,pp. : 2757-2765

Informa Healthcare

Access to resources Recommend Favorite

Safety, Pharmacokinetics, and Pharmacodynamics of Single and Multiple Luseogliflozin Dosing in Healthy Japanese Males: A Randomized, Single-Blind, Placebo-Controlled Trial

By Sasaki Takashi   Seino Yutaka   Fukatsu Atsushi   Sakai Soichi   Samukawa Yoshishige  

Advances in Therapy, Vol. 31, Iss. 3, 2014-03 ,pp. : 345-361

Springer Publishing Company

Access to resources Recommend Favorite

Memory Complaints Are Frequent but Qualitatively Different in Young and Elderly Healthy People

By  

Gerontology, Vol. 56, Iss. 3, 2009-09 ,pp. : 272-277

Karger

Access to resources Recommend Favorite

Napping and 24‐Hour Sleep/Wake Patterns in Healthy Elderly and Young Adults

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 40, Iss. 8, 1992-08 ,pp. : 779-786

John Wiley & Sons Inc

Access to resources Recommend Favorite